Clinical Trial Update: Tetrathiomolybdate in Hormone Refractory Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tetrathiomolybdate for hormone-refractory prostate cancer has completed. No efficacy or outcome details are provided in the sn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Tetrathiomolybdate (tetrathiomolybdate)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED